00600nas a2200181   4500000000100000000000100001008004100002100001600043700001400059700001400073700001800087700001600105700001800121245024800139300001100387490000600398022001400404       2019                            d1 aR. Williams1 aW. Kothny1 aC. Serban1 aS. Lopez-Leon1 aF. de Vries1 aR. Schlienger00aAssociation between vildagliptin and risk of angioedema, foot ulcers, skin lesions, hepatic toxicity, and serious infections in patients with type 2 diabetes mellitus: A European multidatabase, noninterventional, postauthorization safety study  ae000840 v2  a2398-9238